Use of oligomers of lactic acid in the treatment of gynaecological disorders

US8425894B2 · kind B2 · utility

Assignee

• LACCURE AB · SE

Inventors

• Greg Batcheller · Brussels, BE
• Thomas Hedner · Gällstad, SE
• Joergen Johnsson · Helsingborg, SE
• Werner Schubert · Mölndal, SE
• Christer Sjoegren · Viken, SE
• Olov Sterner · Eidsvold, AU
• Malgorzat Sznitowska · Gdańsk, PL

Key dates

• Filing date: Mar 28, 2008
• Grant date: Apr 23, 2013
• Expiry date: Jul 21, 2029

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Use of the one or more oligomers of lactic acid with the following formula (I) wherein n is an integer from 2 to 25 such as, e.g., from 2 to 20, from 3 to 25, from 3 to 20, from 2 to 15, from 3 to 15, from 2 to 10, from 3 to 10, from 4 to 10, or from 4 to 9 or a lactic acid oligomeric product for the prophylaxis and/or treatment of a disease or condition that benefit of an acidic environment especially a gynaecological infection such as a bacterial infection, such as bacterial vaginosis, unspecific colpitis, senile colpitis, cervicitis, and urethritis, a fungal infection, such as candidosis (Candida albicans), cryptococcosis, actinomycosis, or a viral infection, such as Human Immunodefiency Virus (HIV), Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV).